AI-generated summary
The authors report a single female case of facial hyperpigmentation in a hemodialysis patient treated with 1064-nm Q-switched Nd:YAG laser. Significant improvement occurred after three sessions, but spotted leucoderma developed at the fourth visit and persisted at one-year follow-up. The authors suggest the leucoderma reflected laser-induced melanocyte damage from unsuitable application.
- Participants
- 1
- Who or what was studied
- One female patient with end-stage renal disease on hemodialysis and facial hyperpigmentation
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The report describes a single case, so the findings cannot be generalized.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.